Collaboration expands research of new delivery platform beyond liver tissues supporting potential preclinical development and strengthens Singapore’s position as a biomedical innovation hub SINGAPORE, May 20, 2026 /PRNewswire/ — Agilent Technologies Inc. (NYSE: A) today announced a two-year research collaboration agreement with Singapore’s Nucleic Acid Therapeutics Initiative (NATi), hosted by Agency for Science, Technology and Research [...] The post Agilent and Singapore’s NATi Partner to Advance Lipid-Conjugated Oligonucleotide Research appeared first on Australian Business Announcements .
Agilent and Singapore’s NATi Partner to Advance Lipid-Conjugated Oligonucleotide Research
